The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Open accessAbstract
Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are serious health problems worldwide. These two diseases have similar pathological spectra, ranging from simple steatosis to hepatitis to cirrhosis and hepatocellular carcinoma. Although most people with excessive alcohol or calorie intake display abnormal fat accumulation in the liver (simple steatosis), a small percentage develops progressive liver disease. Despite extensive research on understanding the pathophysiology of both these diseases there are still no targeted therapies available. The treatment for ALD remains as it was 50 years ago: abstinence, nutritional support and corticosteroids (or pentoxifylline as an alternative if steroids are contraindicated). As for NAFLD, the treatment modality is mainly directed toward weight loss and co-morbidity management. Therefore, new pathophysiology directed therapies are urgently needed. However, the involvement of several inter-related pathways in the pathogenesis of these diseases suggests that a single therapeutic agent is unlikely to be an effective treatment strategy. Hence, a combination therapy towards multiple targets would eventually be required. In this review, we delineate the treatment options in ALD and NAFLD, including various new targeted therapies that are currently under investigation. We hope that soon we will be having an effective multi-therapeutic regimen for each disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
S-adenosyl-L-methionine for alcoholic liver diseases
Rambaldi, A., & Gluud, C. N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002235.pub2 · Cited by 134
RetractedYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Early Liver Transplantation for Severe Alcoholic Hepatitis
Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F., Castel, H., Duhamel, A., Pageaux, G.-P., Leroy, V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105703 · Cited by 960
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931
Sookoian, S., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 920
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Lucey, M. R., Mathurin, P., & Morgan, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0805786 · Cited by 863
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Prednisolone or Pentoxifylline for Alcoholic Hepatitis
Thursz, M. R., Richardson, P., Allison, M., Austin, A., Bowers, M., Day, C. P., Downs, N., Gleeson, D., MacGilchrist, A., Grant, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412278 · Cited by 769
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Louvet, A., Naveau, S., Abdelnour, M., Ramond, M.-J., Diaz, E., Fartoux, L., Dharancy, S., Texier, F., Hollebecque, A., Serfaty, L., et al. (2007) · Hepatology · doi:10.1002/hep.21607 · Cited by 733
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721
Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13264 · Cited by 717
Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
Akiyama, K., Chen, C., Wang, D., Xu, X., Qu, C., Yamaza, T., Cai, T., Chen, W., Sun, L., & Shi, S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.007 · Cited by 705
Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice
Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 701
TNF and MAP kinase signalling pathways
Sabio, G., & Davis, R. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.009 · Cited by 700
ESPEN Guidelines on Enteral Nutrition: Liver disease
Plauth, M., Cabré, E., Riggio, O., Assis-Camilo, M., Pirlich, M., Kondrup, J., Ferenci, P., Holm, E., vom Dahl, S., Müller, M. J., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.018 · Cited by 688
EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy
Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03153.x · Cited by 685
Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., Abenavoli, L., D'Angelo, C., Caputo, F., Zambon, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61814-5 · Cited by 685
Osteopontin: role in immune regulation and stress responses
Wang, K. X., & Denhardt, D. T. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.001 · Cited by 669
Excess weight risk factor for alcoholic liver disease
Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., & Chaput, J. (1997) · Hepatology · doi:10.1002/hep.510250120 · Cited by 666
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 585
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 564
Ding, X., Saxena, N. K., Lin, S., Gupta, N., & Anania, F. A. (2006) · Hepatology · doi:10.1002/hep.21006 · Cited by 557
Alcohol and Oxidative Liver Injury
Dey, A., & Cederbaum, A. I. (2006) · Hepatology · doi:10.1002/hep.20957 · Cited by 557
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
The regulation of inflammation by galectin‐3
Henderson, N. C., & Sethi, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00794.x · Cited by 522
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
Terai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., Yokoyama, Y., Uchida, K., Yamasaki, T., Fujii, Y., et al. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0542 · Cited by 491
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
Kirpich, I. A., Solovieva, N. V., Leikhter, S. N., Shidakova, N. A., Lebedeva, O. V., Sidorov, P. I., Bazhukova, T. A., Soloviev, A. G., Barve, S. S., McClain, C. J., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.08.006 · Cited by 488
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Kuo, T. K., Hung, S., Chuang, C., Chen, C., Shih, Y. V., Fang, S. Y., Yang, V. W., & Lee, O. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.015 · Cited by 466
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Li Volti, G., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 455
Mathurin, P., O'Grady, J., Carithers, R. L., Phillips, M., Louvet, A., Mendenhall, C. L., Ramond, M.-J., Naveau, S., Maddrey, W. C., & Morgan, T. R. (2011) · Gut · doi:10.1136/gut.2010.224097 · Cited by 455
Naveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.-A., Davion, T., Oberti, F., Broët, P., & Emilie, D. (2004) · Hepatology · doi:10.1002/hep.20206 · Cited by 446
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431
Management of Alcohol Withdrawal Delirium<subtitle>An Evidence-Based Practice Guideline</subtitle>
Mayo-Smith, M. F. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1405 · Cited by 418
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414
The interleukin-17 pathway is involved in human alcoholic liver disease # †
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., et al. (2009) · Hepatology · doi:10.1002/hep.22680 · Cited by 394
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., & Sheppard, B. L. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03553.x · Cited by 394
Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., Keeffe, E. B., Kneteman, N. M., Lake, J. R., Martin, P., McDiarmid, S. V., et al. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030613 · Cited by 391
Cabré, E., Rodríguez-Iglesias, P., Caballería, J., Quer, J. C., Sánchez-Lombraña, J. L., Parés, A., Papo, M., Planas, R., & Gassull, M. A. (2000) · Hepatology · doi:10.1053/jhep.2000.8627 · Cited by 378
Seven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
Aller, R., de Luis, D. A., Izaola, O., Conde, R., Sagrado, M. G., Primo, D., Fuente, B. D. L., & González‐Gallego, J. (2011) · PubMed · Cited by 371
Louvet, A., Wartel, F., Castel, H., Dharancy, S., Hollebecque, A., Canva–Delcambre, V., Deltenre, P., & Mathurin, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.062 · Cited by 367
Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes
Drucker, D. J. (2007) · Diabetes Care · doi:10.2337/dc07-0228 · Cited by 367
Bajaj, M., Suraamornkul, S., Piper, P., Hardies, L. J., Glass, L., Cersosimo, E., Pratipanawatr, T., Miyazaki, Y., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031315 · Cited by 358
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 358
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
Zein, C. O., Yerian, L. M., Gogate, P., Lopez, R., Kirwan, J. P., Feldstein, A. E., & McCullough, A. J. (2011) · Hepatology · doi:10.1002/hep.24544 · Cited by 356
Mathurin, P., Mendenhall, C. L., Carithers, R. L., Ramond, M.-J., Maddrey, W. C., Garstide, P., Rueff, B., Naveau, S., Chaput, J.-C., & Poynard, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00289-6 · Cited by 353
Aurich, H., Sgodda, M., Kaltwaßer, P., Vetter, M., Weise, A., Liehr, T., Brulport, M., Hengstler, J. G., Dollinger, M. M., Fleig, W. E., et al. (2009) · Gut · doi:10.1136/gut.2008.154880 · Cited by 346
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336
Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
Foster, D. W. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63967 · Cited by 336
Burra, P., Senzolo, M., Adam, R., Delvart, V., Karam, V., Germani, G., & Neuberger, J. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02869.x · Cited by 335
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Cui, J., Philo, L., Nguyen, P., Hofflich, H., Hernandez, C., Bettencourt, R., Richards, L., Salotti, J., Bhatt, A., Hooker, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.021 · Cited by 326
Lefebvre, E., Moyle, G., Reshef, R., Richman, L. P., Thompson, M., Hong, F., Chou, H.-L., Hashiguchi, T., Plato, C., Poulin, D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158156 · Cited by 323
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, J. W., Konopski, Z., Eggesbø, H. B., von Volkmann, H. L., Raschpichler, G., Bjøro, K., Haaland, T., Løberg, E. M., & Birkeland, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902845268 · Cited by 323
Zelber–Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., & Oren, R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.004 · Cited by 317
Jeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Basaranoglu, M., Acbay, O., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 305
Gary-Bobo, M., Elachouri, G., Gallas, J. F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
LOOMBA, R., LUTCHMAN, G., KLEINER, D. E., RICKS, M., FELD, J. J., BORG, B. B., MODI, A., NAGABHYRU, P., SUMNER, A. E., LIANG, T. J., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03869.x · Cited by 299
Dew, M. A., DiMartini, A. F., Steel, J., De Vito Dabbs, A., Myaskovsky, L., Unruh, M., & Greenhouse, J. (2008) · Liver Transplantation · doi:10.1002/lt.21278 · Cited by 294
Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic Hepatitis
Felver, M. E., Mezey, E., McGuire, M., Mitchell, M. C., Herlong, H. F., Veech, G. A., & Veech, R. L. (1990) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1990.tb00482.x · Cited by 294
Michelena, J., Altamirano, J., Abraldes, J. G., Affò, S., Morales‐Ibanez, O., Sancho‐Bru, P., Dominguez, M., García‐Pagán, J. C., Fernández, J., Arroyo, V., et al. (2015) · Hepatology · doi:10.1002/hep.27779 · Cited by 291
Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G. A. K., Davies, N. A., & Jalan, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.015 · Cited by 288
Harriman, G., Greenwood, J., Bhat, S., Huang, X., Wang, R., Paul, D., Tong, L., Saha, A. K., Westlin, W. F., Kapeller, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520686113 · Cited by 287
Alcoholic liver disease: pathogenesis and new targets for therapy
Altamirano, J., & Bataller, R. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.134 · Cited by 284
When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
Di Lella, S., Sundblad, V., Cerliani, J. P., Guardia, C. M., Estrin, D. A., Vasta, G. R., & Rabinovich, G. A. (2011) · Biochemistry · doi:10.1021/bi201121m · Cited by 282
B VITAMIN DEFICIENCY AND NEUROPSYCHIATRIC SYNDROMES IN ALCOHOL MISUSE
COOK, C. C. H., HALLWOOD, P. M., & THOMSON, A. D. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008400 · Cited by 281
Safadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., Safadi, R., Konikoff, F. M., Hershkovitz, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.038 · Cited by 274
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
Charlton, M., Kasparova, P., Weston, S., Lindor, K., Maor-Kendler, Y., Wiesner, R. H., Rosen, C. B., & Batts, K. P. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25453 · Cited by 261
Louvet, A., Teixeira-Clerc, F., Chobert, M.-N., Deveaux, V., Pavoine, C., Zimmer, A., Pecker, F., Mallat, A., & Lotersztajn, S. (2011) · Hepatology · doi:10.1002/hep.24524 · Cited by 261
Alcohol, Smoking, Cofee, and Cirrhosis
klatsky, A. L., & Armstrong, M. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116433 · Cited by 257
Wernicke-Korsakoff-syndrome: Under-recognized and under-treated
Isenberg-Grzeda, E., Kutner, H. E., & Nicolson, S. E. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.04.008 · Cited by 253
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
Witek, R. P., Stone, C. W., Karaca, G. F., Syn, W.-K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., et al. (2009) · Hepatology · doi:10.1002/hep.23167 · Cited by 253
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Clinical use of anti-TNF therapy and increased risk of infections
Ali, T., Bronze, Kaitha, Mahmood, Ftaisi, & Stone (2013) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s28801 · Cited by 242
Benefits of lifestyle modification in NAFLD
Harrison, S. A., & Day, C. P. (2007) · Gut · doi:10.1136/gut.2006.112094 · Cited by 240
Dominguez, M., Miquel, R., Colmenero, J., Moreno, M., García–Pagán, J., Bosch, J., Arroyo, V., Ginès, P., Caballería, J., & Bataller, R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.056 · Cited by 238
Verbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236
Thomson, A. D. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.supplement_1.2 · Cited by 236
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
Trépo, E., Nahon, P., Bontempi, G., Valenti, L., Falleti, E., Nischalke, H.-D., Hamza, S., Corradini, S. G., Burza, M. A., Guyot, E., et al. (2014) · Hepatology · doi:10.1002/hep.26767 · Cited by 233
Myths and Misconceptions of Wernicke’s Encephalopathy: What Every Emergency Physician Should Know
Donnino, M. W., Vega, J., Miller, J., & Walsh, M. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.02.007 · Cited by 228
Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?
Pageaux, G.-P., Bismuth, M., Perney, P., Costes, V., Jaber, S., Possoz, P., Fabre, J.-M., Navarro, F., Blanc, P., Domergue, J., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00088-6 · Cited by 225
Purohit, V., Abdelmalek, M. F., Barve, S., Benevenga, N. J., Halsted, C. H., Kaplowitz, N., Kharbanda, K. K., Liu, Q.-Y., Lu, S. C., McClain, C. J., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.14 · Cited by 221
Self-citationRecent advances in the development of farnesoid X receptor agonists.
Ali, A. H., Carey, E. J., & Lindor, K. D. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2014.12.06 · Cited by 221
Mathurin, P., Abdelnour, M., Ramond, M.-J., Carbonell, N., Fartoux, L., Serfaty, L., Valla, D., Poupon, R., Chaput, J.-C., & Naveau, S. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.038 · Cited by 220
Protein energy malnutrition predicts complications in liver cirrhosis
Huisman, E. J., Trip, E. J., Siersema, P. D., van Hoek, B., & van Erpecum, K. J. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834aa4bb · Cited by 217
Mendenhall, C., Roselle, G. A., Gartside, P., Moritz, T., & 275, T. V. A. C. S. G. 1. A. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01560.x · Cited by 216
Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
Solga, S. F., & Diehl, A. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00097-7 · Cited by 210
Mathurin, P., Louvet, A., Duhamel, A., Nahon, P., Carbonell, N., Boursier, J., Anty, R., Diaz, E., Thabut, D., Moirand, R., et al. (2013) · JAMA · doi:10.1001/jama.2013.276300 · Cited by 210
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 208
Influence of Alcohol on the Progression of Hepatitis C Virus Infection: A Meta-analysis
Hutchinson, S. J., Bird, S. M., & Goldberg, D. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00407-6 · Cited by 208
RAMBALDI, A., SACONATO, H. H., CHRISTENSEN, E., THORLUND, K., WETTERSLEV, J., & GLUUD, C. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03685.x · Cited by 206
Paik, Y.-H., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Österreicher, C. H., Kisseleva, T., & Brenner, D. A. (2011) · Hepatology · doi:10.1002/hep.24281 · Cited by 204
Kharbanda, K. K., Mailliard, M. E., Baldwin, C. R., Beckenhauer, H. C., Sorrell, M. F., & Tuma, D. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.024 · Cited by 200
Self-citationFriedman, S., Sanyal, A., Goodman, Z., Lefebvre, E., Gottwald, M., Fischer, L., & Ratziu, V. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.02.012 · Cited by 197
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis
Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., Record, C., & Day, C. P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.027 · Cited by 196
Pellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., Fiorucci, S., Clerici, C., & Gioiello, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049904b · Cited by 194
Endocannabinoids in liver disease
Tam, J., Liu, J., Mukhopadhyay, B., Cinar, R., Godlewski, G., & Kunos, G. (2011) · Hepatology · doi:10.1002/hep.24077 · Cited by 194
Jang, Y. O., Kim, Y. J., Baik, S. K., Kim, M. Y., Eom, Y. W., Cho, M. Y., Park, H. J., Park, S. Y., Kim, B. R., Kim, J. W., et al. (2014) · Liver International · doi:10.1111/liv.12218 · Cited by 194
Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., Seeff, L. B., & for the National Heart, L. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00012 · Cited by 194
Veldt, B. J., Lainé, F., Guillygomarc'h, A., Lauvin, L., Boudjema, K., Messner, M., Brissot, P., Deugnier, Y., & Moirand, R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00228-8 · Cited by 191
Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Bedogni, G., Caputo, F., Gasbarrini, G., Landolfi, R., the Baclofen Study Group, Nesci, A., et al. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agr017 · Cited by 191
FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
Wu, X., Ge, H., Lemon, B., Vonderfecht, S., Weiszmann, J., Hecht, R., Gupte, J., Hager, T., Wang, Z., Lindberg, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068783 · Cited by 183
Úbeda, M., Lario, M., Muñoz, L., Borrero, M.-J., Rodríguez-Serrano, M., Sánchez-Díaz, A.-M., del Campo, R., Lledó, L., Pastor, Ó., García-Bermejo, L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.010 · Cited by 178
Schwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.005 · Cited by 178
Horiguchi, N., Wang, L., Mukhopadhyay, P., Park, O., Jeong, W. I., Lafdil, F., Osei–Hyiaman, D., Moh, A., Fu, X. Y., Pacher, P., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.016 · Cited by 178
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
Van Wagner, L. B., Koppe, S. W. P., Brunt, E. M., Gottstein, J., Gardikiotes, K., Green, R. M., & Rinella, M. E. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31539-x · Cited by 173
cJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170
Juurlink, D. N., Gomes, T., Lipscombe, L. L., Austin, P. C., Hux, J. E., & Mamdani, M. M. (2009) · BMJ · doi:10.1136/bmj.b2942 · Cited by 170
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.
Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., & Lowenstam, I. (1986) · PubMed · Cited by 166
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., Doganay, L., & Enc, F. Y. (2011) · Medical Science Monitor · doi:10.12659/msm.881749 · Cited by 165
The Evolution and Treatment of Korsakoff's Syndrome: Out of Sight, Out of Mind?
Thomson, A. D., Guerrini, I., & Marshall, E. J. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9196-z · Cited by 164
Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance
Sabio, G., Kennedy, N. J., Cavanagh, J., Jung, D. Y., Ko, H. J., Ong, H., Barrett, T., Kim, J. K., & Davis, R. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01162-09 · Cited by 164
VLACHOGIANNAKOS, J., SAVERIADIS, A. S., VIAZIS, N., THEODOROPOULOS, I., FOUDOULIS, K., MANOLAKOPOULOS, S., RAPTIS, S., & KARAMANOLIS, D. G. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03958.x · Cited by 163
Singh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. (2015) · Hepatology · doi:10.1002/hep.27999 · Cited by 163
Self-citationEzetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Zheng, S., Hoos, L., Cook, J., Tetzloff, G., Davis, H., van Heek, M., & Hwa, J. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.045 · Cited by 163
Mu, J., Pinkstaff, J., Li, Z., Skidmore, L., Li, N., Myler, H., Dallas-Yang, Q., Putnam, A.-M., Yao, J., Bussell, S., et al. (2012) · Diabetes · doi:10.2337/db11-0838 · Cited by 162
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Day, C., & Anstee, Q. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562947 · Cited by 161
Simopoulos, A. P. (2013) · Nutrients · doi:10.3390/nu5082901 · Cited by 161
Zein, C. O., Lopez, R., Fu, X., Kirwan, J. P., Yerian, L. M., McCullough, A. J., Hazen, S. L., & Feldstein, A. E. (2012) · Hepatology · doi:10.1002/hep.25778 · Cited by 160
Nutritional support in patients with chronic liver disease
Henkel, A. S., & Buchman, A. L. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0443 · Cited by 159
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
Affò, S., Morales‐Ibanez, O., Rodrigo‐Torres, D., Altamirano, J., Blaya, D., Dapito, D. H., Millán, C., Coll, M., Caviglia, J. M., Arroyo, V., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306098 · Cited by 158
Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial
De, B. K., Gangopadhyay, S., Dutta, D., Baksi, S. D., Pani, A., & Ghosh, P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1613 · Cited by 154
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Y. S., & Shah, V. H. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.4.337 · Cited by 152
Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
JOY, T. R., McKenzie, C. A., Tirona, R. G., Summers, K. L., Seney, S. L., Chakrabarti, S., Malhotra, N., & Beaton, M. D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i1.141 · Cited by 152
Moon, H.-J., Finney, J., Ronnebaum, T. A., & Mure, M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.07.003 · Cited by 151
Weinsier, R. L., Wilson, L. J., & Lee, J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80394-5 · Cited by 148
Nutrition and Alcoholic Liver Disease
Halsted, C. H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-832941 · Cited by 148
Fibroblast Growth Factor Signaling in Metabolic Regulation
Nies, V. J. M., Sancar, G., Liu, W., van Zutphen, T., Struik, D., Yu, R. T., Atkins, A. R., Evans, R. M., Jonker, J. W., & Downes, M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00193 · Cited by 147
Raetsch, C., Jia, J. D., Boigk, G., Bauer, M., Hahn, E. G., Riecken, E.-O., & Schuppan, D. (2002) · Gut · doi:10.1136/gut.50.2.241 · Cited by 143
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4153-y · Cited by 139
Li, L., Jie, H., Li, Z., Zhang, Y., Peng, H., Li, K., & Weng, X. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.08.036 · Cited by 137
Carino, A., Cipriani, S., Marchianò, S., Biagioli, M., Santorelli, C., Donini, A., Zampella, A., Monti, M. C., & Fiorucci, S. (2017) · Scientific Reports · doi:10.1038/srep42801 · Cited by 137
Lonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., Zona, S., & Targher, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9674 · Cited by 135
Xiang, M., Wang, P., Wang, A., Zhang, X., Zhang, Y., Zhang, P., Mei, F., Chen, M., & Li, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.002 · Cited by 133
Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
Du, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.569 · Cited by 131
Risco, A., del Fresno, C., Mambol, A., Alsina‐Beauchamp, D., MacKenzie, K. F., Yang, H., Barber, D. F., Morcelle, C., Arthur, J. S. C., Ley, S. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207290109 · Cited by 130
Alcoholic Liver Disease and Methionine Metabolism
Kharbanda, K. K. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214371 · Cited by 128
Self-citationIncretin mimetics as a novel therapeutic option for hepatic steatosis
Tushuizen, M. E., Bunck, M. C. M., Pouwels, P. J. W., van Waesberghe, J. H. T., Diamant, M., & Heine, R. J. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01315.x · Cited by 127
Sabuncu, T., Nazlıgül, Y., Karaoğlanoğlu, M., Uçar, E., & Kilic, F. B. (2003) · PubMed · Cited by 126
Dipeptidyl peptidase IV (DDP IV) in NASH patients
Balaban, Y. H., Korkusuz, P., Simsek, H., Gokcan, H., Gedikoglu, G., Pinar, A., Hascelik, G., Asan, E., Hamaloglu, E., & Tatar, G. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31905-2 · Cited by 125
Iwasaki, T., Yoneda, M., Inamori, M., Shirakawa, J., Higurashi, T., Maeda, S., Terauchi, Y., & Nakajima, A. (2011) · Hepatogastroenterology · doi:10.5754/hge11263 · Cited by 124
Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis
Fialla, A. D., Israelsen, M. E., Hamberg, O., Krag, A. A., & Gluud, L. L. (2015) · Liver International · doi:10.1111/liv.12798 · Cited by 123
Firneisz, G., Varga, T., Lengyel, G., Fehér, J., Ghyczy, D., Wichmann, B., Selmeci, L., Tulassay, Z., Rácz, K., & Somogyi, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012226 · Cited by 121
Stem cell therapies for liver failure and cirrhosis
Zhang, Z., & Wang, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.018 · Cited by 119
Zinc prevention and treatment of alcoholic liver disease
Kang, Y. J., & Zhou, Z. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.002 · Cited by 118
Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse
Day, E., Bentham, P., Callaghan, R., Kuruvilla, T., & George, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004033.pub2 · Cited by 117
Management of Alcohol Dependence in Patients with Liver Disease
Addolorato, G., Mirijello, A., Leggio, L., Ferrulli, A., & Landolfi, R. (2013) · CNS Drugs · doi:10.1007/s40263-013-0043-4 · Cited by 117
Stiede, K., Miao, W., Blanchette, H., Beysen, C., Harriman, G. C. B., Harwood, H. J., Kelley, H., Kapeller, R., Schmalbach, T., & Westlin, W. (2017) · Hepatology · doi:10.1002/hep.29246 · Cited by 117
Fuchs, M. A. (2011) · Journal of Lipids · doi:10.1155/2012/934396 · Cited by 114
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis
González‐Terán, B., Cortés, J. R., Manieri, E., Matesanz, N., Verdugo, Á., Rodríguez, M. E., González‐Rodríguez, Á., Valverde, Á. M., Martín, P., Davis, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65124 · Cited by 114
Lee, J. H., Kang, Y. E., Chang, J. Y., Park, K. C., Kim, H.-W., Kim, J. T., Kim, H. J., Yi, H., Shong, M., Chung, H. K., et al. (2016) · PubMed · Cited by 114
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 113
Alcoholic Liver Disease and Malnutrition
McClain, C. J., Barve, S. S., Barve, A. J., & Marsano, L. S. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01405.x · Cited by 112
Dumortier, J., Guillaud, O., Adham, M., Boucaud, C., Delafosse, B. X., Bouffard, Y., Paliard, P., Scoazec, J., & Boillot, O. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01079.x · Cited by 111
De novo malignancies following liver transplantation: Impact and recommendations
Herrero, J. I. (2009) · Liver Transplantation · doi:10.1002/lt.21898 · Cited by 111
Steatohepatitis and fatal hepatic failure after biliopancreatic diversion.
Grimm, I. S., Schindler, W. R., & Haluszka, O. (1992) · PubMed · Cited by 110
Christopoulou, F., & Kiortsis, D. N. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01164.x · Cited by 110
Balkestein, E. J., van Aggel‐Leijssen, D. P., van Baak, M. A., Struijker-Boudier, H. A. J., & Bortel, L. M. V. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00008 · Cited by 104
la Tijera, F. H., Servín-Caamaño, A. I., Serralde-Zúñiga, A. E., Cruz-Herrera, J., Pérez-Torres, E., Abdo-Francis, J. M., Salas-Gordillo, F., & Pérez-Hernández, J. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i16.4975 · Cited by 103
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
Morales‐Ibanez, O., Domínguez, M., Ki, S. H., Marcos, M., Chaves, F. J., Nguyen-Khac, É., Houchi, H., Affò, S., Sancho‐Bru, P., Altamirano, J., et al. (2013) · Hepatology · doi:10.1002/hep.26521 · Cited by 101
Roozen, H. G., de Waart, R., van der Windt, D., van den Brink, W., de Jong, C. A. J., & Kerkhof, A. J. F. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.001 · Cited by 97
Histological features after liver transplantation in alcoholic cirrhotics
Burra, P., Mioni, D., Cecchetto, A., Cillo, U., Zanus, G., FAGIUOLI, S., Naccarato, R., & Martines, D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00002-2 · Cited by 96
Acamprosate for Alcohol Dependence: A Sex‐Specific Meta‐Analysis Based on Individual Patient Data
Mason, B. J., & Lehert, P. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01616.x · Cited by 95
Ostawal, A., Mocevic, E., Kragh, N., & Xu, W. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0180-0 · Cited by 91
p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration
González‐Terán, B., Matesanz, N., Nikolić, I., Verdugo, M. A., Sreeramkumar, V., Hernández‐Cosido, L., Mora, A., Crainiciuc, G., Sáiz, M. L., Bernardo, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201591857 · Cited by 90
Intestinal microflora in patients with liver cirrhosis
Zhao, H. Y., Wang, H. J., Lü, Z., & Xu, S. Z. (2004) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2004.00157.x · Cited by 89
Cited by
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Apoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Beneficial Effects of Betaine: A Comprehensive Review
Arumugam, M. K., Paal, M. C., Donohue, T. M., Ganesan, M., Osna, N. A., & Kharbanda, K. K. (2021) · Biology · doi:10.3390/biology10060456 · Cited by 291
Self-citationBenedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242
“132 MASLD management is a complex condition associated with factors like obesity, arterial hypertension, IR, and abnormal lipid profiles, that typically requires an intricate intervention once diagnosed.”
BackgroundLeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
“Other than what has already been mentioned, interventions for MASLD [ 351 ] N u t r iti on a l s uppo r t: V it a m i n s li k e f o l a t e , v it a m i n B 6 , v it a m i n B 12 , v it a - m i n A , a nd t h i a m i n e [ 351 ] M i n e r a l s ( li k e s e l e n i u m , z i n c , c opp e r , a nd…”
BackgroundInfluential
Metadata
- Authors
- Singh, S., Osna, N. A., & Kharbanda, K. K.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017-09-28
- Volume
- 23
- Issue
- 36
- Pages
- 6549-6570
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2758047358
- Cited by
- 257
- References
- 245
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.